Trials / Recruiting
RecruitingNCT06215625
A Feasible Smart Upper Limb Rehabilitation Model for Patients With Stroke and Spinal Cord Injuries
Establishment of a Feasible Smart Upper Limb Rehabilitation Model in Post-pandemic Era: Examples for Patients With Stroke and Spinal Cord Injuries
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- National Cheng-Kung University Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to investigate the effectiveness of the developed application and exoskeleton robot devices for home-based training in stroke patients and patients with spinal cord injuries. The application that uses an Internet of Things (IoT) platform to enable remote monitoring of rehabilitation progress by clinical practitioners. Simultaneously, it seeks to assist the execution of patient movements through devices. In patients with stroke, half of the participants will be assigned to experimental group, receiving a smart upper limb motor rehabilitation system for home program. The other half will be assigned to control group, receiving a traditional home program. In patients with spinal cord injuries. Participants will follow the same allocation method for home-based intervention. Researchers will conduct an analysis before and after intervention, examining progress in motor function, activities of daily living, and quality of life.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Robot-assisted therapy | The TIGER system provides assistance for activities of daily living. Continuous passive mode of TIGER system provides passive range of motion as warm-up. Functional mode TIGER system provides functional training. |
| OTHER | Task-oriented training | The TOT group will practice sensorimotor techniques for warming up, and then they will practice various functional tasks based on task-oriented approach. |
Timeline
- Start date
- 2024-01-01
- Primary completion
- 2026-06-01
- Completion
- 2026-12-31
- First posted
- 2024-01-22
- Last updated
- 2024-01-22
Locations
2 sites across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT06215625. Inclusion in this directory is not an endorsement.